The growing biotech industry has led to an increasingly competitive and saturated marketplace, and with it, greater competition for face time with premier thought leaders. Coupled with the scrutiny associated with industry partnerships and the challenges of managing KOL relationships in a post-Sunshine Act world, it is imperative for life science organizations to differentiate themselves from their competitors in the marketplace while aligning company objectives across their internal organization.
The 9th KOL/Thought Leader Engagement and Advisory Boards Summit will provide attendees with valuable insights into engaging traditional and non-traditional KOLs and discuss the priorities and motivating factors for patient groups, payers and managed care organizations. Join our esteemed faculty as they share disruptive techniques for attracting external stakeholders in meaningful ways and discuss strategies for commercial and medical groups to work together while maintaining compliance.
Top Five Reasons to Attend
- Redefine the idea of thought leaders to include key stakeholders that truly represent the current healthcare landscape
- Develop clearly defined objectives that are aligned across internal and external groups to ensure the success of an advisory board
- Adapt traditional collaboration with KOLs to fit into the digital pharma world
- Examine how new stakeholders - including payers, IDN networks, and healthcare quality leaders - are acquiring more influence over treatment decision-making
- Craft compliant processes to collect and evaluate data in order to determine regional and international fair market value rates
Who Should Attend
This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:- KOL Relationship Management/Development
- Opinion/Thought Leader Relations
- Medical Science Liaison
- Brand/Product Management
- Medical and Professional Affairs
- Medical and Professional Education
- Scientific/Medical Communication, Relations and Affairs
- Advisory Board Management
- Speaker Bureau Training/Management
- Speaker Programs
- Professional Education/Programs
- Global Relations
- Compliance, Legal and Regulations
- Business Development
- CRM Systems
- Sales and Marketing
- Professional Relations
- External Affairs
- Stakeholder Relations/Outreach
- Medical Publications
- Physician Education/Outreach
- Promotional Regulatory Affairs
This conference is also of interest to:
- KOL Management, Social Network Analysis (SNA) and KOL Identifiers
- KOL Technology/Software Providers
- KOL Identification and Mapping Services
- Digital Advisory Board Service Providers
- Conferencing Software Providers
- Communication and Public Speaking Bureaus
- Law Firms
- Aggregate Spend Professionals
Venue
Sonesta Philadelphia Hotel Rittenhouse Square1800 Market St.
Philadelphia, PA 19130
Explore the comfort and fresh, contemporary vibe at the all-new Sonesta Philadelphia. A premier choice among hotels in Philadelphia, enjoy spacious, modern accommodations and luxurious amenities while staying in the heart of downtown and only steps away from Rittenhouse Square.
To make reservations, guests can call 1-800-SONESTA (766-3782) and request the group rate for ExL’s June Meetings.
To make reservations online: CLICK HERE
The group rate is available until May 21, 2018. Please book your room early, as rooms available at this rate are limited.
Speakers
- Kevin Appareti, Senior Director, Global MSL, PHILIPS HEALTHCARE
- Pamela Appel, Director, Strategic Support and External Engagement, KOL Relations, PFIZER
- J. Lynn Bass, Director, Medical Science Liaisons, SANTEN
- Leslie Bloom, Director, Scientific Education and Patient Advocacy, JOHNSON AND JOHNSON
- Natalia Borinshteyn, President, LIFE SCIENCE EXCELLENCE INC.
- Milijana Drobnjak, Regional Director of Sales, GILEAD SCIENCES
- Vicki L. Fisher, Director, Operations and Training, Medical Affairs, JAZZ PHARMACEUTICALS
- Usman Iqbal, Senior Director, Medical Affairs and HEOR, TREVENA
- Jon Kaskey, Senior Director, Business Partnerships, WITHIN3
- Peter Kowey, M.D., FACC, FHRS, FAHA, Professor of Medicine and Clinical Pharmacology, Jefferson Medical College, The William Wikoff Smith Chair in Cardiovascular Research, LANKENAU HOSPITAL AND MEDICAL RESEARCH CENTER
- Chijioke O. Madugwulike, Senior Manager, Clinical and Health Economics Outcomes Research, OSIRIS THERAPEUTICS, INC
- Dan Mintz, Vice President, Business Development, IBM WATSON HEALTH
- Yurek Paprocki, M.D., MBA, Medical Lead Director, NOVO NORDISK, INC
- Vimal Patel, PHARM.D., Senior Director, Customer Engagement, SUN PHARMACEUTICALS
- William Soliman, Executive Chair, ACMA
- Gail Spahn, Executive Director, Scientific Affairs, ACELRX
- Amanda Sweeney, Senior Vice President, Client Success, WITHIN3
The agenda is available as PDF under downloads at the right side of the page.